Patents Assigned to Purdue Pharmaceuticals, L.P.
  • Patent number: 8524275
    Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: September 3, 2013
    Assignees: Purdue Pharma L.P., The P.F Laboratories, Inc., Purdue Pharmaceuticals, L.P.
    Inventors: Benjamin Oshlack, Curtis Wright, Christopher Breder
  • Patent number: 8389007
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Grant
    Filed: October 30, 2008
    Date of Patent: March 5, 2013
    Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals, L.P.
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder